A. M. Abd El-Aty, PhD, Cairo University, Egypt
Christine Meisinger, MPH, University of Augsburg, Germany
Lipids in Health and Disease ranks in the top percentile of Springer Nature journals based on data collected from the Journal Author Satisfaction Survey. Editorial excellence recognizes extraordinary editors for their commitment and passion to their journals. Learn more about editorial excellence here. Thank you and congratulations to the journal’s Editors-in-Chief, A. M. Abd El-Aty and Christine Meisinger.
This article discusses the challenges posed by the surge in Mendelian randomization studies, particularly 2SMR. It recommends that editors and reviewers enforce stricter criteria and rigorous testing to filter out low-quality research and prevent misleading conclusions. Read full article here.
We are excited to publish new Review article by Undurti N. Das, titled Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations? Read full article here and related blog post, written by Prof. Das on this topic.
This interesting research article highlights “a novel underlying mechanism, why consuming PL-rich foods such as fish and dairy may reduce the risk of developing dementia and associated disorders.” Read full article here.
Lipids in Health and Disease is calling for submissions to our new Collection on Environmental Exposures and Lipid Homeostasis: Investigating the Impact of Pollutants on Metabolic Health. This Collection focuses on the link between environmental factors and lipid homeostasis.
Lipids in Health and Disease is calling for submissions to our new Collection on "Lipids and Women’s Health" which will explore two thematic areas: Lipids in Reproductive Diseases in Women and Influence of Gender Bias on Recent Lipid Studies.
Lipids in Health and Disease is calling for submissions to our new Collection on "Lipids and Sleep". This Collection is focusing on the link between sleep and lipid metabolism. We invite original research, topical and systematic review articles and meta-analyses. For more information on the scope please click here.
Lipids in Health and Disease is calling for submissions to our new Collection on "Nanomaterials/Biomaterials Target Lipid Metabolism and Fight Diseases". With this Collection we hope to provide a platform for communication and discussion of the pharmacological mechanism of nanobiotechnology and lipid metabolism. Read more about the scope here.
Have a submission you want to make sure is right for Lipids in Health and Disease? Or a great idea for a new submission or thematic series? Tell our Editors-in-Chief, A. M. Abd El-Aty and Christine Meisinger!
A. M. Abd El-Aty, PhD, Cairo University, Egypt
Christine Meisinger, MPH, University of Augsburg, Germany
Lipids in Health and Disease is an open access, peer-reviewed journal that publishes articles on all aspects of lipids: their interaction with proteins, (bio)chemistry, (molecular) pharmacology, (molecular) toxicology, natural products chemistry, role in health and disease, in addition to the synthesis of new lipid compounds, and enzyme systems involved in lipid metabolism.
Lipids in Health and Disease is aimed at all scientists, health professionals, and physicians interested in lipids. Lipids are defined herein based on their broadest sense and include cholesterol, triacylglycerol, fatty acids, phospholipids, sphingolipids, glycosphingolipids, remnant cholesterol, inositol lipids, second messenger lipids, and other storage and bioactive forms of these molecules. Other topics of interest include enzymes and synthetic machinery that are involved in the metabolism of various lipids in cells and tissues and various aspects of lipid transport. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology, and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.
Citation Impact 2023
Journal Impact Factor: 3.9
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.220
SCImago Journal Rank (SJR): 1.112
Speed 2023
Submission to first editorial decision (median days): 1
Submission to acceptance (median days): 68
Usage 2023
Downloads: 1,810,907
Altmetric mentions: 1,488